X Zhang, D-S Liu, Z-S Luan, F Zhang, X-H Liu, W Zhou, S-F Zhong, H Lai. Clin Transl Oncol 2018
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Kenichi Nakanishi, Toyone Kikumori, Noriyuki Miyajima, Yuko Takano, Sumiyo Noda, Dai Takeuchi, Shingo Iwano, Yasuhiro Kodera. Clin Nucl Med 2018
Kenichi Nakanishi, Toyone Kikumori, Noriyuki Miyajima, Yuko Takano, Sumiyo Noda, Dai Takeuchi, Shingo Iwano, Yasuhiro Kodera. Clin Nucl Med 2018
50
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
50
Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study.
Renfei Wang, Yueqian Zhang, Jian Tan, Guizhi Zhang, Ruiguo Zhang, Wei Zheng, Yajing He. Medicine (Baltimore) 2017
Renfei Wang, Yueqian Zhang, Jian Tan, Guizhi Zhang, Ruiguo Zhang, Wei Zheng, Yajing He. Medicine (Baltimore) 2017
50
RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
Pan Chen, Hui-Juan Feng, Wei Ouyang, Ju-Qing Wu, Jing Wang, Yun-Gang Sun, Jia-Lang Xian, Liu-Hua Huang. Endocr Pract 2016
Pan Chen, Hui-Juan Feng, Wei Ouyang, Ju-Qing Wu, Jing Wang, Yun-Gang Sun, Jia-Lang Xian, Liu-Hua Huang. Endocr Pract 2016
50
Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer.
Fabián Pitoia, Fernanda Bueno, Graciela Cross. Clin Nucl Med 2014
Fabián Pitoia, Fernanda Bueno, Graciela Cross. Clin Nucl Med 2014
50
Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Hong-Jun Song, Zhong-Ling Qiu, Chen-Tian Shen, Wei-Jun Wei, Quan-Yong Luo. Eur J Endocrinol 2015
Hong-Jun Song, Zhong-Ling Qiu, Chen-Tian Shen, Wei-Jun Wei, Quan-Yong Luo. Eur J Endocrinol 2015
50
Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.
Takuro Isoda, Shingo BaBa, Yasuhiro Maruoka, Yoshiyuki Kitamura, Keiichiro Tahara, Masayuki Sasaki, Hiroshi Honda. Ann Nucl Med 2016
Takuro Isoda, Shingo BaBa, Yasuhiro Maruoka, Yoshiyuki Kitamura, Keiichiro Tahara, Masayuki Sasaki, Hiroshi Honda. Ann Nucl Med 2016
50
A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study.
Yue-Jun Fu, Na An, Kok-Gan Chan, Yan-Bo Wu, Shu-Hua Zheng, Ai-Hua Liang. Biotechnol Lett 2011
Yue-Jun Fu, Na An, Kok-Gan Chan, Yan-Bo Wu, Shu-Hua Zheng, Ai-Hua Liang. Biotechnol Lett 2011
25
Efficacy and safety of bevacizumab for the treatment of glioblastoma.
Zhiyun Yu, Gang Zhao, Zhonghua Zhang, Yunqian Li, Yong Chen, Nan Wang, Zhongying Zhao, Guifang Xie. Exp Ther Med 2016
Zhiyun Yu, Gang Zhao, Zhonghua Zhang, Yunqian Li, Yong Chen, Nan Wang, Zhongying Zhao, Guifang Xie. Exp Ther Med 2016
25
Bevacizumab in brain tumors: ready for primetime?
Enrico Franceschi, Alicia Tosoni, Fabio Girardi, Alba A Brandes. Future Oncol 2009
Enrico Franceschi, Alicia Tosoni, Fabio Girardi, Alba A Brandes. Future Oncol 2009
25
Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.
Yongjun Cheng, Jinhua Zhao, Wenli Qiao, Kai Chen. Am J Nucl Med Mol Imaging 2014
Yongjun Cheng, Jinhua Zhao, Wenli Qiao, Kai Chen. Am J Nucl Med Mol Imaging 2014
25
131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors.
Frank Grünwald, Samer Ezziddin. Semin Nucl Med 2010
Frank Grünwald, Samer Ezziddin. Semin Nucl Med 2010
25
25
Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk.
Su Kang Kim, Sang Wook Kang, Hae Jeong Park, Ju Yeon Ban, Chung-Hun Oh, Joo-Ho Chung, In-Hwan Oh, Kyu Bong Cho, Min-Su Park. Int J Clin Exp Med 2015
Su Kang Kim, Sang Wook Kang, Hae Jeong Park, Ju Yeon Ban, Chung-Hun Oh, Joo-Ho Chung, In-Hwan Oh, Kyu Bong Cho, Min-Su Park. Int J Clin Exp Med 2015
25
Use of chlorotoxin for targeting of primary brain tumors.
L Soroceanu, Y Gillespie, M B Khazaeli, H Sontheimer. Cancer Res 1998
L Soroceanu, Y Gillespie, M B Khazaeli, H Sontheimer. Cancer Res 1998
25
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Adam N Mamelak, Steven Rosenfeld, Richard Bucholz, Andrew Raubitschek, L Burt Nabors, John B Fiveash, Sui Shen, M B Khazaeli, David Colcher, An Liu,[...]. J Clin Oncol 2006
Adam N Mamelak, Steven Rosenfeld, Richard Bucholz, Andrew Raubitschek, L Burt Nabors, John B Fiveash, Sui Shen, M B Khazaeli, David Colcher, An Liu,[...]. J Clin Oncol 2006
25
Tumor suppression by stromal TIMPs.
Masayuki Shimoda, Hartland W Jackson, Rama Khokha. Mol Cell Oncol 2016
Masayuki Shimoda, Hartland W Jackson, Rama Khokha. Mol Cell Oncol 2016
25
Matrix metalloproteinases: regulators of the tumor microenvironment.
Kai Kessenbrock, Vicki Plaks, Zena Werb. Cell 2010
Kai Kessenbrock, Vicki Plaks, Zena Werb. Cell 2010
25
Recurrent glioblastoma multiforme: a review of natural history and management options.
Lewis C Hou, Anand Veeravagu, Andrew R Hsu, Victor C K Tse. Neurosurg Focus 2006
Lewis C Hou, Anand Veeravagu, Andrew R Hsu, Victor C K Tse. Neurosurg Focus 2006
25
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
George Sgouros, Katherine S Kolbert, Arif Sheikh, Keith S Pentlow, Edward F Mun, Axel Barth, Richard J Robbins, Steven M Larson. J Nucl Med 2004
George Sgouros, Katherine S Kolbert, Arif Sheikh, Keith S Pentlow, Edward F Mun, Axel Barth, Richard J Robbins, Steven M Larson. J Nucl Med 2004
25
Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus.
J A DeBin, G R Strichartz. Toxicon 1991
J A DeBin, G R Strichartz. Toxicon 1991
25
Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas.
Yue-Jun Fu, Li-Tian Yin, Ai-Hua Liang, Chao-Feng Zhang, Wei Wang, Bao-Feng Chai, Jian-Yi Yang, Xiao-Jun Fan. Neurosci Lett 2007
Yue-Jun Fu, Li-Tian Yin, Ai-Hua Liang, Chao-Feng Zhang, Wei Wang, Bao-Feng Chai, Jian-Yi Yang, Xiao-Jun Fan. Neurosci Lett 2007
25
Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways.
Yan Su, Daqian Wan, Wenqi Song. Anticancer Drugs 2016
Yan Su, Daqian Wan, Wenqi Song. Anticancer Drugs 2016
25
Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent.
Jinhua Zhao, Wenli Qiao, Yuna Zhang, Xiaoxia Shao. Cancer Biother Radiopharm 2010
Jinhua Zhao, Wenli Qiao, Yuna Zhang, Xiaoxia Shao. Cancer Biother Radiopharm 2010
25
Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Lisa M Coussens, Barbara Fingleton, Lynn M Matrisian. Science 2002
Lisa M Coussens, Barbara Fingleton, Lynn M Matrisian. Science 2002
25
Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
Susan A Lyons, Jeffrey O'Neal, Harald Sontheimer. Glia 2002
Susan A Lyons, Jeffrey O'Neal, Harald Sontheimer. Glia 2002
25
Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
Kathrin Klutz, David Schaffert, Michael J Willhauck, Geoffrey K Grünwald, Rudolf Haase, Nathalie Wunderlich, Christian Zach, Franz J Gildehaus, Reingard Senekowitsch-Schmidtke, Burkhard Göke,[...]. Mol Ther 2011
Kathrin Klutz, David Schaffert, Michael J Willhauck, Geoffrey K Grünwald, Rudolf Haase, Nathalie Wunderlich, Christian Zach, Franz J Gildehaus, Reingard Senekowitsch-Schmidtke, Burkhard Göke,[...]. Mol Ther 2011
25
Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
Sui Shen, M B Khazaeli, G Yancey Gillespie, Vernon L Alvarez. J Neurooncol 2005
Sui Shen, M B Khazaeli, G Yancey Gillespie, Vernon L Alvarez. J Neurooncol 2005
25
The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Magdalena Groblewska, Maria Siewko, Barbara Mroczko, Maciej Szmitkowski. Folia Histochem Cytobiol 2012
Magdalena Groblewska, Maria Siewko, Barbara Mroczko, Maciej Szmitkowski. Folia Histochem Cytobiol 2012
25
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
Martin Schlumberger, Bogdan Catargi, Isabelle Borget, Désirée Deandreis, Slimane Zerdoud, Boumédiène Bridji, Stéphane Bardet, Laurence Leenhardt, Delphine Bastie, Claire Schvartz,[...]. N Engl J Med 2012
Martin Schlumberger, Bogdan Catargi, Isabelle Borget, Désirée Deandreis, Slimane Zerdoud, Boumédiène Bridji, Stéphane Bardet, Laurence Leenhardt, Delphine Bastie, Claire Schvartz,[...]. N Engl J Med 2012
25
Flavonoids and genomic instability induced by ionizing radiation.
Seyed Jalal Hosseinimehr. Drug Discov Today 2010
Seyed Jalal Hosseinimehr. Drug Discov Today 2010
25
A neurocentric perspective on glioma invasion.
Vishnu Anand Cuddapah, Stefanie Robel, Stacey Watkins, Harald Sontheimer. Nat Rev Neurosci 2014
Vishnu Anand Cuddapah, Stefanie Robel, Stacey Watkins, Harald Sontheimer. Nat Rev Neurosci 2014
25
Imaging glioma extent with 131I-TM-601.
David C Hockaday, Sui Shen, John Fiveash, Andrew Raubitschek, David Colcher, An Liu, Vern Alvarez, Adam N Mamelak. J Nucl Med 2005
David C Hockaday, Sui Shen, John Fiveash, Andrew Raubitschek, David Colcher, An Liu, Vern Alvarez, Adam N Mamelak. J Nucl Med 2005
25
25
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients.
M Leo, E Sabini, I Ionni, A Sframeli, B Mazzi, F Menconi, E Molinaro, F Bianchi, F Brozzi, P Santini,[...]. J Endocrinol Invest 2018
M Leo, E Sabini, I Ionni, A Sframeli, B Mazzi, F Menconi, E Molinaro, F Bianchi, F Brozzi, P Santini,[...]. J Endocrinol Invest 2018
25
131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Angela Spanu, Maria E Solinas, Francesca Chessa, Daniela Sanna, Susanna Nuvoli, Giuseppe Madeddu. J Nucl Med 2009
Angela Spanu, Maria E Solinas, Francesca Chessa, Daniela Sanna, Susanna Nuvoli, Giuseppe Madeddu. J Nucl Med 2009
25
BmKCT toxin inhibits glioma proliferation and tumor metastasis.
Shaozhong Fan, Zhengbo Sun, Dahe Jiang, Chao Dai, Yibao Ma, Zhenhuan Zhao, Hui Liu, Yingliang Wu, Zhijian Cao, Wenxin Li. Cancer Lett 2010
Shaozhong Fan, Zhengbo Sun, Dahe Jiang, Chao Dai, Yibao Ma, Zhenhuan Zhao, Hui Liu, Yingliang Wu, Zhijian Cao, Wenxin Li. Cancer Lett 2010
25
TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis.
P Valente, G Fassina, A Melchiori, L Masiello, M Cilli, A Vacca, M Onisto, L Santi, W G Stetler-Stevenson, A Albini. Int J Cancer 1998
P Valente, G Fassina, A Melchiori, L Masiello, M Cilli, A Vacca, M Onisto, L Santi, W G Stetler-Stevenson, A Albini. Int J Cancer 1998
25
Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2.
Jessy Deshane, Craig C Garner, Harald Sontheimer. J Biol Chem 2003
Jessy Deshane, Craig C Garner, Harald Sontheimer. J Biol Chem 2003
25
Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches.
Richard Schulz. Annu Rev Pharmacol Toxicol 2007
Richard Schulz. Annu Rev Pharmacol Toxicol 2007
25
How matrix metalloproteinases regulate cell behavior.
M D Sternlicht, Z Werb. Annu Rev Cell Dev Biol 2001
M D Sternlicht, Z Werb. Annu Rev Cell Dev Biol 2001
25
Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.
W G Stetler-Stevenson. Am J Pathol 1996
W G Stetler-Stevenson. Am J Pathol 1996
25
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Rita C S Figueira, Luciana R Gomes, João S Neto, Fabricio C Silva, Ismael D C G Silva, Mari C Sogayar. BMC Cancer 2009
Rita C S Figueira, Luciana R Gomes, João S Neto, Fabricio C Silva, Ismael D C G Silva, Mari C Sogayar. BMC Cancer 2009
25
The role of the organ microenvironment in the biology and therapy of cancer metastasis.
Isaiah J Fidler, Sun-Jin Kim, Robert R Langley. J Cell Biochem 2007
Isaiah J Fidler, Sun-Jin Kim, Robert R Langley. J Cell Biochem 2007
25
Biology and biochemistry of proteinases in tumor invasion.
P Mignatti, D B Rifkin. Physiol Rev 1993
P Mignatti, D B Rifkin. Physiol Rev 1993
25
Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?
Dorina Ylli, Kenneth D Burman, Douglas Van Nostrand, Leonard Wartofsky. J Clin Endocrinol Metab 2018
Dorina Ylli, Kenneth D Burman, Douglas Van Nostrand, Leonard Wartofsky. J Clin Endocrinol Metab 2018
25
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
A M Samuel, B Rajashekharrao, D H Shah. J Nucl Med 1998
A M Samuel, B Rajashekharrao, D H Shah. J Nucl Med 1998
25
Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.
Ryan K Orosco, Timon Hussain, Kevin T Brumund, Deborah K Oh, David C Chang, Michael Bouvet. Thyroid 2015
Ryan K Orosco, Timon Hussain, Kevin T Brumund, Deborah K Oh, David C Chang, Michael Bouvet. Thyroid 2015
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.